Dr. Besserer-Offroy Elie

Dr. Besserer-Offroy Elie

Research Fellow

McGill University
Montréal, Canada

plus Speciality



Élie earned a diploma in biochemistry, cell biology and physiology from Université de Franche-Comté (Besançon, France) in 2009; in 2010 he obtained his Bachelor in medical sciences (BMSc, Medical Biochemistry) from Université Claude Bernard – Lyon I (Villeurbanne, France). After eight months of internship at the Institute for Biology and Chemistry of Proteins (Lyon, France) where he studied the interaction between ABCG2 and the Human serum albumin in drug resistance. Élie decided to join the dept. of pharmacology of the Université de Sherbrooke (QC, Canada) for his MSc in pharmacology in October 2010. He worked on the development of a BRET-Based assay for high throughput screening in collaboration with U. Montréal and a biotech company. In 2012, Élie started his PhD in pharmacology working on GPCRs signalization with the aim to discover new therapeutics for pain management.

Academic positions:

Post-Doctoral Research Associate, Department of Pharmacology and Therapeutics, McGill University

Faculty Lecturer, Faculty of Pharmacy, Université de Montréal

Research interests:

Élie's research focuses on non opioid G-protein coupled receptors as new drug targets for the treatment of chronic pain. More precisely Élie is interested to decipher the signalization of those receptors leading to analgesia and unwanted effects in order to synthesize new biased analogs with fewer side effects.

What I think of the idea behind WebmedCentral and WebmedCentral plus:

I think WebmedCentral could be a new model of publication and a new way for peer-review. The post-publication peer-review could lead to a discussion and not to a impairment of the submitted work.